Related Experiment Video
Updated: May 9, 2026
Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
Published on: September 5, 2025
Current status of robotic distal pancreatectomy: a systematic review
Roberto Cirocchi1, Stefano Partelli, Andrea Coratti
1Digestive Surgery and Liver Unit, S. Maria Hospital, Via Tristano di Joannuccio n.4, Terni 05100, Italy. cirocchiroberto@yahoo.it
Objective:
The aim of this systematic review is to determine the potential advantages of robotic distal pancreatectomy (RDP).
Study Selection:
Both randomized and non-randomized studies.
Data Extraction:
Two investigators independently selected studies for inclusion by article abstraction and full text reviewing.
Data Synthesis:
Five non-RCTs were included in the review. The feasibility of RDP (95.4%) and spleen-preserving rate is between 50% and 100%. Mean OT varied between 298 min and 398 min with only completely robotic procedures, whereas mean OT was 293 in "laparoscopic/robotic" technique. Postoperative length of hospital stay ranged from 7 days to 13.7 days. The 30-day postoperative overall morbidity resulted between 0 and 18% of patients.
Conclusions:
RDP is an emergent technology for which there are not yet sufficient data to draw definitive conclusions with respect to conventional or laparoscopic surgery. The mean duration of RDP is longer with Da Vinci robot, but hospital stay is shorter even if it is influenced by hospital protocols. We cannot make any conclusions comparing the outcomes to laparoscopic or open procedures here, since none of these studies are randomized, and we all know that most of these surgeons selected the easier cases for robotic procedures. For these reasons randomized controlled trials are recommended to better evaluate RDP cost-effectiveness.
